InflaRx N.V. Recorded Big Gain
Wed, Apr 05, 2023 at 07:08 PM
InflaRx N.V. (IFRX:NASDAQ) jumped higher at $6.1, representing a gain of 61.8%. On Wed, Apr 05, 2023, IFRX:NASDAQ hit a New 2-Week High of $6.1. The stock appeared on our News Catalysts scanner on Wed, Apr 05, 2023 at 03:20 PM in the 'BIOTECH' category. From Wed, Mar 22, 2023, the stock recorded 60.00% Up Days and 81.82% Green Days
About InflaRx N.V. (IFRX:NASDAQ)
InflaRx NV is a biopharmaceutical company. It discovers and develops potent and specific inhibitors of the complement activation factor known as C5a.
Top 10 Gainers:
- Jowell Global Ltd. (JWEL:NASDAQ), 146.47%
- Liminal BioSciences Inc. (LMNL:NASDAQ), 77.78%
- InflaRx N.V. (IFRX:NASDAQ), 61.8%
- Nuburu Inc. (BURU:NYSEMKT), 56.99%
- Scilex Holding Company Com (SCLX:NASDAQ), 56.57%
- Virgin Orbit Holdings Inc. (VORB:NASDAQ), 34.23%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 31.76%
- Freight Technologies Inc Com (FRGT:NASDAQ), 30.41%
- Creatd Inc. (CRTD:NASDAQ), 26.62%
- Vallon Pharmaceuticals Inc. (VLON:NASDAQ), 25.71%